查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1437514

氯雷他定市场，按等级类型、剂型、最终用途、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Loratadine Market, By Grade Type, By Dosage Form, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年氯雷他定市场规模为 1.555 亿美元，2024 年至 2032 年复合CAGR为 2.8%。

氯雷他定市场-市场动态

几种过敏症的流行推动市场需求

由于许多过敏性疾病（包括皮肤过敏、过敏性鼻炎、过敏性气喘、过敏性结膜炎和过敏性鼻炎）的发病率不断增加，因此对疾病管理中的有效治疗方法的需求量很大。遗传倾向、生活方式的改变和环境变数是造成高疾病负担的原因。例如，美国过敏、气喘和免疫学院报告称，2021 年，全球 18-44 岁年龄层的人中有超过 25.7% 经历过季节性过敏。此外，花粉热影响超过 7.8% 的 18 岁及以上美国人。因此，在不久的将来，预计高收入和中等收入国家不断上升的疾病负担和人口变化将推动市场需求。

氯雷他定市场 - 主要见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 2.8% 左右的CAGR成长

根据牌号类型细分，USP 标准牌号类别主导市场

根据剂型细分，片剂细分市场在 2023 年占据最大市场份额

根据最终用途细分，预计线上药局领域在预测期内将以最高CAGR成长

按地区划分，北美是 2023 年的主要收入来源

氯雷他定市场-区隔分析：

全球氯雷他定市场根据等级类型、剂型、最终用途和地区进行细分。

市场依等级类型分为四类：EP标准级、USP标准级、医药标准级及其他。 USP 标准等级类别主导市场。 USP 标准等级非常注重遵守品质和安全规则，这反过来又提高了消费者的偏好和采用率。

市场依剂型分为四大类：胶囊剂、锭剂、糖浆剂及其他。平板电脑细分市场在 2023 年占据最大的市场份额，预计在预测期内将继续保持相同的格局。这主要是因为大的、经授权的药丸形式很容易获得且易于服用。

根据最终用途，市场分为三类：零售药房、医院药房和线上药房。预计线上药局领域在预测期内将以最高的CAGR成长。该细分市场的成长归因于便利性、可近性以及对数位健康解决方案日益增长的偏好等因素。

氯雷他定市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。预计北美将在预测期内引领市场，因为该地区过敏发生率高，医疗保健系统完善，并且是氯雷他定生产和营销领域的主要参与者。此外，活跃的管线和氯雷他定预计日益增强的适应性将促进预测期内的区域成长。美国气喘与过敏基金会 2022 年的研究指出，约 25 个主要城市属于过敏反应高风险类别。

氯雷他定市场-竞争格局：

市场上的主要参与者包括卡迪拉製药公司、Perrigo Company plc、拜耳公司、Morepen Laboratories Ltd、Viatris Inc.、辉瑞公司、Sun Pharmaceutical Industries Limited、Lannett、东京化学工业有限公司、Claritin、Merck KGaA ，Cipla Inc. 为了进入新市场，市场参与者不断采取各种策略性倡议，包括创造新产品、融资和投资、併购以及其他策略伙伴关係。

最近的发展：

2022 年1 月，Institut d'Investigacio Biomedica de Bellvitge 赞助了一项名为「氯雷他定对淋巴管平滑肌瘤病(LORALAM) 的影响」的临床试验，以评估氯雷他定在LAM 中的安全性和可能的​​优势，LAM 是一种以进行性囊性肺破坏为特征的罕见致命疾病。

目录

第一章：氯雷他定市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按等级类型分類的氯雷他定市场片段
    • 氯雷他定市场片段（按剂型）
    • 以最终用途分類的氯雷他定市场片段
    • 按国家/地区分類的氯雷他定市场片段
    • 按地区分類的氯雷他定市场片段
  • 竞争洞察

第 3 章：氯雷他定主要市场趋势

  • 氯雷他定市场驱动因素
    • 市场驱动因素的影响分析
  • 氯雷他定市场限制
    • 市场限制影响分析
  • 氯雷他定市场机会
  • 氯雷他定市场未来趋势

第 4 章：氯雷他定产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：氯雷他定市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：氯雷他定市场格局

  • 2023 年氯雷他定市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：氯雷他定市场 - 依等级类型

  • 概述
    • 按等级类型分類的细分市场占有率分析
    • EP标准级
    • USP 标准等级
    • 医药标准级
    • 其他的

第 8 章：氯雷他定市场 - 按剂型

  • 概述
    • 按剂型分類的细分市场份额分析
    • 胶囊
    • 平板电脑
    • 糖浆
    • 其他的

第 9 章：氯雷他定市场 - 依最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 零售药房
    • 医院药房
    • 网路药房

第 10 章：氯雷他定市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美氯雷他定主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按等级类型）
    • 北美市场规模与预测（按剂型）
    • 北美市场规模和预测（按最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲氯雷他定主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按等级类型）
    • 欧洲市场规模与预测（按剂型）
    • 欧洲市场规模和预测（按最终用途）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 氯雷他定亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依等级类型）
    • 亚太地区市场规模与预测（按剂型）
    • 亚太地区市场规模和预测（按最终用途）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲氯雷他定主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按等级类型）
    • 拉丁美洲市场规模与预测（按剂型）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲氯雷他定主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（依等级类型）
    • 中东和非洲市场规模及预测（按剂型）
    • 中东和非洲市场规模和预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 氯雷他定产业

  • 竞争仪表板
  • 公司简介
    • Cadila Pharmaceuticals
    • Perrigo Company plc
    • Bayer AG
    • Morepen Laboratories Ltd
    • Viatris Inc.
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Limited
    • Lannett
    • Tokyo Chemical Industry Co., Ltd.
    • Claritin
    • Merck KGaA
    • Cipla Inc

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2232

REPORT HIGHLIGHT

Loratadine Market size was valued at USD 155.5 Million in 2023, expanding at a CAGR of 2.8% from 2024 to 2032.

The short-term relief of hay fever symptoms, which are caused by allergies to dust, pollen, or other airborne particles, is achieved with the use of loratadine. Sneezing, runny nose, and itchy eyes, nose, or throat are some of these symptoms. Additionally, loratadine is utilized to relieve hive-related redness and itching. But loratadine doesn't stop allergic skin responses like hives. Loratadine belongs to the group of drugs known as antihistamines. It functions by preventing the body's natural production of histamine, which is a chemical that triggers allergic reactions.

Loratadine Market- Market Dynamics

Growing prevalence of several allergies to propel market demand

Effective treatments in disease management will be in high demand due to the increasing frequency of many allergic disorders, including skin allergies, allergic rhinitis, allergic asthma, allergic conjunctivitis, and allergic rhinitis. Genetic predispositions, changing lifestyles, and environmental variables are responsible for the high illness burden. For instance, the American Academy College of Allergy, Asthma & Immunology reports that in 2021, over 25.7% of people worldwide in the 18-44 age range experienced seasonal allergies. Also, hay fever affects more than 7.8% of Americans who are 18 years of age and older. In the near future, it is thus expected that the rising illness burden and demographic change in high- and middle-income nations would drive market demand.

Loratadine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 2.8% over the forecast period (2024-2032)

Based on grade type segmentation, the USP Standard Grade category dominates the market

Based on the dosage form segmentation, tablets segment held the largest market share in 2023

Based on end-use segmentation, the online pharmacy segment is expected to grow at the highest CAGR during the forecast period

Based on region, North America was the leading revenue generator in 2023

Loratadine Market- Segmentation Analysis:

The Global Loratadine Market is segmented based on Grade Type, Dosage Form, End-Use, and Region.

The market is divided into four categories based on grade type: EP Standard Grade, USP Standard Grade, Medicine Standard Grade and Others. The USP Standard Grade category dominates the market. The USP standard grade places a strong focus on adhering to quality and safety rules, which in turn increases consumer preference and adoption rates.

The market is divided into four categories based on the dosage form: Capsules, Tablets, Syrup and Others. The tablets segment held the largest market share in 2023 and is expected to continue the same pattern during the forecast period. This is mostly because large, authorized pill forms are readily available and are simple to administer.

The market is divided into three categories based on end-use: Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. The online pharmacy segment is expected to grow at the highest CAGR during the forecast period. The segment growth is attributed to factors such as convenience, accessibility, and a growing preference for digital health solutions.

Loratadine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to lead the market during the forecast period because the area has a high incidence of allergies, a well-established healthcare system, and major participants in the loratadine production and marketing sectors. Moreover, it is projected that active pipelines and loratadine's increasing adaptability would promote regional growth over the projection period. The Asthma and Allergy Foundation of America's 2022 study states that about 25 major cities fall into the high-risk category for allergic reactions.

Loratadine Market- Competitive Landscape:

The key players operating in the market are Cadila Pharmaceuticals, Perrigo Company plc, Bayer AG, Morepen Laboratories Ltd, Viatris Inc., Pfizer Inc., Sun Pharmaceutical Industries Limited, Lannett, Tokyo Chemical Industry Co., Ltd., Claritin, Merck KGaA, Cipla Inc. To obtain access to new markets, market players are continuously pursuing a variety of strategic initiatives, including the creation of new products, funding and investments, mergers and acquisitions, and other strategic partnerships.

Recent Developments:

In January 2022, Institut d'Investigacio Biomedica de Bellvitge is sponsoring a clinical trial called "Effect of Loratadine in Lymphangioleiomyomatosis (LORALAM)" to evaluate the safety and possible advantages of loratadine in LAM, a rare and fatal disease marked by progressive cystic lung destruction.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LORATADINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Cadila Pharmaceuticals

Perrigo Company plc

Bayer AG

Morepen Laboratories Ltd

Viatris Inc.

Pfizer Inc.

Sun Pharmaceutical Industries Limited

Lannett

Tokyo Chemical Industry Co., Ltd.

Claritin

Merck KGaA

Cipla Inc

GLOBAL LORATADINE MARKET, BY GRADE TYPE- MARKET ANALYSIS, 2019 - 2032

  • EP Standard Grade
  • USP Standard Grade
  • Medicine Standard Grade
  • Others

GLOBAL LORATADINE MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Capsules
  • Tablets
  • Syrup
  • Others

GLOBAL LORATADINE MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

GLOBAL LORATADINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Loratadine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Loratadine Market Snippet by Grade Type
    • 2.1.2. Loratadine Market Snippet by Dosage Form
    • 2.1.3. Loratadine Market Snippet by End-Use
    • 2.1.4. Loratadine Market Snippet by Country
    • 2.1.5. Loratadine Market Snippet by Region
  • 2.2. Competitive Insights

3. Loratadine Key Market Trends

  • 3.1. Loratadine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Loratadine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Loratadine Market Opportunities
  • 3.4. Loratadine Market Future Trends

4. Loratadine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Loratadine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Loratadine Market Landscape

  • 6.1. Loratadine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Loratadine Market - By Grade Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Grade Type, 2023 & 2032 (%)
    • 7.1.2. EP Standard Grade
    • 7.1.3. USP Standard Grade
    • 7.1.4. Medicine Standard Grade
    • 7.1.5. Others

8. Loratadine Market - By Dosage Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
    • 8.1.2. Capsules
    • 8.1.3. Tablets
    • 8.1.4. Syrup
    • 8.1.5. Others

9. Loratadine Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
    • 9.1.2. Retail Pharmacy
    • 9.1.3. Hospital Pharmacy
    • 9.1.4. Online Pharmacy

10. Loratadine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Loratadine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Loratadine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Loratadine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Loratadine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Loratadine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Loratadine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Cadila Pharmaceuticals
    • 11.2.2. Perrigo Company plc
    • 11.2.3. Bayer AG
    • 11.2.4. Morepen Laboratories Ltd
    • 11.2.5. Viatris Inc.
    • 11.2.6. Pfizer Inc.
    • 11.2.7. Sun Pharmaceutical Industries Limited
    • 11.2.8. Lannett
    • 11.2.9. Tokyo Chemical Industry Co., Ltd.
    • 11.2.10. Claritin
    • 11.2.11. Merck KGaA
    • 11.2.12. Cipla Inc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Loratadine Market: Grade Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Grade Type
  • TABLE Global Loratadine Market, by Grade Type 2019-2032 (USD Million)
  • TABLE Loratadine Market: Dosage Form Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Dosage Form
  • TABLE Global Loratadine Market, by Dosage Form 2019-2032 (USD Million)
  • TABLE Loratadine Market: End-UseSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-Use
  • TABLE Global Loratadine Market, by End-Use2019-2032 (USD Million)
  • TABLE Loratadine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Loratadine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE North America Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE North America Loratadine Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Europe Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE Europe Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Europe Loratadine Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Asia Pacific Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Asia Pacific Loratadine Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Latin America Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE Latin America Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Latin America Loratadine Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Loratadine Market, by End-Use, 2019-2032 (USD Million)